Sara Badiali

Milan, 20122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The I148M PNPLA3 Variant Forces Progressive Portal MASLD by Spatially Perturbing Metabolic Pathways Across Liver Zones.

The I148M PNPLA3 Variant Forces Progressive Portal MASLD by Spatially Perturbing Metabolic Pathways Across Liver Zones.

Journal: International journal of molecular sciences

Published: December 23, 2025

The KLB rs12152703 variant confers protection against hepatic inflammation in patients with MASLD by boosting Klotho-beta expression.

The KLB rs12152703 variant confers protection against hepatic inflammation in patients with MASLD by boosting Klotho-beta expression.

Journal: JHEP reports : innovation in hepatology

Published: July 14, 2025

Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD.

Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD.

Journal: Obesity (Silver Spring, Md.)

Published: November 03, 2023

A novel gene signature to diagnose MASLD in metabolically unhealthy obese individuals.

A novel gene signature to diagnose MASLD in metabolically unhealthy obese individuals.

Journal: Biochemical pharmacology

Published: October 31, 2023

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value.

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value.

Journal: Frontiers in nutrition

Published: November 17, 2022

MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients.

MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients.

Journal: Journal of internal medicine

Published: October 04, 2021

Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes.

Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes.

Journal: EBioMedicine

Published: October 18, 2019

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker.

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker.

Journal: Gut

Published: June 04, 2019

Body mass index reduction improves the baseline procoagulant imbalance of obese subjects.

Body mass index reduction improves the baseline procoagulant imbalance of obese subjects.

Journal: Journal of thrombosis and thrombolysis

Published: February 01, 2019

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis.

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2018

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients.

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients.

Journal: Journal of lipid research

Published: October 14, 2018

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.

Journal: Hepatology communications

Published: February 27, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026